Asston Pharmaceuticals Ltd.

Our Company is engaged in the manufacturing and export of both pharmaceutical formulations and nutraceutical products indomestic and various African markets. Our Company operates under brand “Asston”. Presently, our Company is involved in thebusiness of manufacturing and marketing of Tablets, Capsules, Oral Liquid, External Preparations (Ointment, Cream, Gel andLotion) and Oral Powder (Sachet, Dry Syrup) etc. Apart from manufacturing products for direct sales, our Company alsomanufactures various pharmaceutical products for different marketers on loan license or on contract manufacturing basis. Ourbusiness is primarily conducted on a principle-to-principle basis with various marketers.As on the date, we cater to multiple corporate clients on loan licence and/or contract manufacturing basis. Currently, our Companyhas its production facility at Ambernath, Maharashtra, for producing generic medicines in the tablet form and nutraceuticalmedicines in the tablet form, syrup and sachet form. We have a dedicated and separate floors for pharmaceutical products andnutraceutical products respectively as the norms and standards are different for both of them and are governed by FDA and FSSAIrespectively. Since the FDA norms for pharmaceutical products are much more stringent, to comply with FDA standards separateguidelines are there to be followed. Facility has total production capacity of up to around 8-9 crore tablets per month. Our Companyproduces an average of 5-6 crore tablets per month, with production capacity varying based on the weight of the medicines. Higherweightmedicines result in lower production quantities and vice versa. The syrup production capacity for nutraceuticals isapproximately 37.5 kiloliters per month, while sachet production capacity ranges from 30 to 40 lakh sachets per month, dependingon the powder weight per sachet. The facility is certified by relevant authorities and undergoes periodic audits by state and centralFDA authorities. It includes a QA/QC unit and a warehouse for storing raw materials and finished goods in designated chambersunder controlled conditions. Our Company engages contract manufacturers to produce generic medicines and antibiotics in variousforms, including tablets, sachets, syrups, and capsules. All contract manufacturers are WHO-GMP certified to ensure their facilitiesand processes comply with applicable standards and industry norms.

Projects

1. Project Name: Funding capital expenditure requirements towards acquiring machinery in the manufacturing unit

Project Cost: 60

2. Project Name: Funding the incremental working capital requirements of our Company

Project Cost: 130

3. Project Name: Repayment and/or prepayment, in part or full, of certain of our outstanding borrowings availed by

Project Cost: 10